Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV

Sponsor
National Center for Complementary and Integrative Health (NCCIH) (NIH)
Overall Status
Completed
CT.gov ID
NCT00057538
Collaborator
University of California, San Diego (Other)
60
1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effectiveness of a stress management group intervention for people with HIV. The study will evaluate several outcomes, including perceived stress, quality of life, psychosocial factors, and physiological measures of stress.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mantram Repetition
Phase 2

Detailed Description

It is well documented that living with HIV/AIDS can cause a great amount of stress, and evidence suggests that stress may hasten HIV disease progression by increasing viral replication and suppressing the immune response. Stress management intervention studies using more complex combinations of cognitive and relaxation therapies have shown improvements in both psychological and physiological measures in HIV infected persons. However, no studies have focused on only one intervention or have addressed the spiritual component using a comparable control group to determine which of these interventions is most effective.

Participants will be randomly assigned to receive either a spiritually-based cognitive intervention to an educational control group. The intervention will be given over a 10-week period, with 5 weekly classes, 4 weekly automated phone calls, and one final class meeting. Assessments will be conducted at pre-intervention, fifth class midpoint, tenth week post-intervention, and 3-month follow-up. Time commitment can vary from 6 months to 9 months, depending on when participants are screened.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Educational/Counseling/Training
Official Title:
Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV
Study Start Date :
May 1, 2003
Study Completion Date :
May 1, 2003

Outcome Measures

Primary Outcome Measures

  1. Intrusive Thoughts []

  2. Perceived Stress []

  3. Trait Anxiety []

  4. Trait Anger []

Secondary Outcome Measures

  1. Spiritual Well-Being (FACIT-SpEx) []

  2. Quality of Life Enjoyment and Satisfaction []

  3. Ways of Coping []

  4. Urinary cortisol levels []

  5. Urinary catecholamines []

  6. Salivary cortisol levels []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • HIV infected for at least 6 months

  • Ability to read and write English

Exclusion Criteria:
  • Drug use within the past 6 months

  • Cognitive impairment or dementia

  • Diagnosis that may affect cortisol levels, such as diabetes, cancer, or asthma

  • Loss of family/loved one in past 3 months

  • Started a relaxation therapy in past 3 months

  • History or current practice of the RISE program, rosary, chanting, or Transcendental Meditation (TM)

  • Acute infection in past month

  • Change of HAART or drug regimen in past month

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA San Diego Healthcare System San Diego California United States 92161

Sponsors and Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)
  • University of California, San Diego

Investigators

  • Principal Investigator: Jill E. Bormann, PhD, RN, California San Diego Healthcare System

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00057538
Other Study ID Numbers:
  • R21AT001159-01A1
First Posted:
Apr 7, 2003
Last Update Posted:
Aug 18, 2006
Last Verified:
Aug 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2006